Tumour immunology: false hopes - new horizons?

被引：29

作者：

Alexandroff, AB

Robins, RA

Murray, A

James, K

机构：

[1] Univ Edinburgh, Royal Infirm, Dept Surg, Edinburgh EH3 9YW, Midlothian, Scotland

[2] Queens Med Ctr, Dept Immunol, Nottingham NG7 2UH, England

[3] Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield, S Yorkshire, England

来源：

IMMUNOLOGY TODAY | 1998年 / 19卷 / 06期

关键词：

D O I：

10.1016/S0167-5699(98)01265-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

For the past 100 years, tumour immunology has witnessed peaks and troughs of interest. A recent meeting* covered new technologies and recent developments in the field.

引用

页码：247 / 250

页数：4

共 16 条

[1] ALEXANDROFF AB, IN PRESS BR J CANC
[2] Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappa B pathway involving TNF receptor-associated factors
Eliopoulos, AG
Stack, M
Dawson, CW
Kaye, KM
Hodgkin, L
Sihota, S
Rowe, M
Young, LS
[J]. ONCOGENE, 1997, 14 (24) : 2899 - 2916
[3] Evans EML, 1997, CANCER RES, V57, P2943
[4] Response of B-cell lymphoma to a combination of bispecific antibodies and saporin
French, RR
Bell, AJ
Hamblin, TJ
Tutt, AL
Glennie, MJ
[J]. LEUKEMIA RESEARCH, 1996, 20 (07) : 607 - 617
[5] GAJEWSKI TF, 1995, J IMMUNOL, V154, P5637
[6] A central role of CD40 ligand in the regulation of CD4(+) T-cell responses
Grewal, IS
Flavell, RA
[J]. IMMUNOLOGY TODAY, 1996, 17 (09): : 410 - 414
[7] EFFECTIVE TUMOR VACCINE GENERATED BY FUSION OF HEPATOMA-CELLS WITH ACTIVATED B-CELLS
GUO, YJ
WU, MC
CHEN, H
WANG, XN
LIU, GL
LI, GL
MA, J
SY, MS
[J]. SCIENCE, 1994, 263 (5146) : 518 - 520
[8] KIENER PA, 1995, J IMMUNOL, V155, P4917
[9] KOHO H, 1984, CANCER IMMUNOL IMMUN, V17, P165
[10] Mackey MF, 1997, CANCER RES, V57, P2569

← 1 2 →